- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 255.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 258.83M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 247.34M sh |
| Shares Outstanding | Q1 2026 · Dec 31, 2025 | 256.04M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $16.84M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $2.57M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $7.35M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $20.12M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $21.61M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $24.74M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $37.43M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $45.06M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $56.24M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$55.91M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$30.47M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$17.17M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$56.36M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $51.45M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $39.45M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $52.95M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $41.02M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $93.1M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $99.8M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $161.26M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $170.05M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $12.15M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $11.23M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $9.41M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $7.84M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8.05M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$9.52M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.06M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$7.98M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $23.37M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $19M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $7.48M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $7.85M |
| Revenue | Q1 2026 · Mar 31, 2026 | $30.84M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $26.85M |